A new series of aryl sulfamate derivatives: design, synthesis, and biological evaluation

Research output: Contribution to journalArticlepeer-review

Authors

  • Mohammed I. El-gamal
  • Seyed-omar Zaraei
  • Hanan S. Anbar
  • Randa El-gamal
  • Raafat El-awady
  • Barry V. L. Potter

Colleges, School and Institutes

Abstract

Steroid sulfatase (STS) has recently emerged as a drug target for management of hormone-dependent malignancies. In the present study, a new series of twenty-one aryl amido-linked sulfamate derivatives 1a-u was designed and synthesized, based upon a cyclohexyl lead compound. All members were evaluated as STS inhibitors in a cell-free assay. Adamantyl derivatives 1h and 1p-r were the most active with more than 90% inhibition at 10 µM concentration and, for those with the greatest inhibitory activity, IC50 values were determined. These compounds exhibited STS inhibition within the range of ca 25–110 nM. Amongst them, compound 1q possessing a o-chlorobenzene sulfamate moiety exhibited the most potent STS inhibitory activity with an IC50 of 26 nM. Furthermore, to assure capability to pass through the cell lipid bilayer, compounds with low IC50 values were tested against STS activity in JEG-3 whole-cell assays. Consequently, 1h and 1q demonstrated IC50 values of ca 14 and 150 nM, respectively. Thus, compound 1h is 31 times more potent than the corresponding cyclohexyl lead (IC50 value = 421 nM in a JEG-3 whole-cell assay). Furthermore, the most potent STS inhibitors (1h and 1p-r) were evaluated for their antiproliferative activity against the estrogen-dependent breast cancer cell line T-47D. They showed promising activity with single digit micromolar IC50 values (ca 1–6 µM) and their potency against T-47D cells was comparable to that against STS enzyme. In conclusion, this new class of adamantyl-containing aryl sulfamate inhibitor has potential for further development against hormone-dependent tumours.

Details

Original languageEnglish
Article number115406
Number of pages9
JournalBioorganic & Medicinal Chemistry
Volume28
Issue number8
Early online date3 Mar 2020
Publication statusPublished - 15 Apr 2020

Keywords

  • adamantyl, antiproliferative activity, breast cancer, JEG-3, steroid sulfatase, T-47D